Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rite Aid Hopes For Greener Pastures After Cutting Grass

Executive Summary

Rite Aid will be operating under a one-year turnaround deadline following the departure of CEO Martin Grass and the infusion of $300 mil. from Leonard Green & Partners.

You may also be interested in...



Rite Aid Sales Slow With OTC Claritin, HRT Slump; Growing Rx Count Is Focus

Rite Aid is attributing its slower growth in prescription drug sales to reduced hormone therapy demand and the Claritin OTC switch

Rite Aid Allegations Include Booking Unearned Rx Rebates By Former Exec

Improper recording of contingent pharmaceutical rebates is among the allegations in a criminal indictment against one current and three former Rite Aid executives

Rite Aid Allegations Include Booking Unearned Rx Rebates By Former Exec

Improper recording of contingent pharmaceutical rebates is among the allegations in a criminal indictment against one current and three former Rite Aid executives

Related Content

UsernamePublicRestriction

Register

PS035061

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel